Helsinn appoints Dr Melanie Rolli as Group Chief Operating :

Helsinn appoints Dr Melanie Rolli as Group Chief Operating Officer Lugano, Switzerland, May 19, 2022 – Helsinn Group, a fully integrated, global biopharma...

Related Keywords

Germany , United States , China , California , Lugano , Ticino , Switzerland , Heidelberg , Baden Wüberg , Ireland , Mannheim , Spain , La Jolla , Barcelona , Comunidad Autonoma De Cataluna , Melanie Rolli , Paola Bonvicini , Giorgio Calderari , Novartis Pharma , Head Of Medical Affairs , Linkedin , Twitter , Dr Melanie Rolli As Group , Helsinn Birex Pharmaceuticals Ltd , Group Drug Development , Novartis Oncology Business Unit For Development Functions , Helsinn Group , Senior Leadership Team , Helsinn As Group , Research Institute For Molecular , Department Of Women Health , University Medical Hospital , Group Head Of Communication , University Of Heidelberg , Group Chief Operating , Group Chief Operating Officer , Fully Integrated Targeted Therapy , Senior Leadership , Portfolio Integration , Novartis Oncology Business Unit , Chief Executive Officer , Piqur Therapeutics , Development Leadership Team , Novartis Oncology , Medical Affairs , Global Head Medical Safety , Group Drug , Medical School , Clinician Medical , Surgical Oncology , Postdoctoral Fellowship , Experimental Medicine , Helsinn Birex Pharmaceuticals , Media Contact , Helsinn Healthcare Sa , Helsinn , R Melanie Rolli , Elix Therape ,